Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Isis, Ciba-Geigy evaluate antisense drug in phase I

April 12, 1996

Gastrimmune phase I/II trial completed

April 12, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Scotia accelerates development of temoporfin

April 5, 1996

Lu-Tex clinical update

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

Oncogene Science, Pfizer extend research agreement

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...